Opportunities in Preclinical Development

With so many people, workflows and science factors involved in pharmaceutical preclinical development, data management can become complex and challenging.

With each domain generating critical data used for investigational new drug submissions (INDs), new drug applications (NDAs), biologics licence applications (BLAs) and regulatory approval, it’s vital you understand data requirements across all preclinical domains.

Download our paper to find out what you need to consider when managing data across all areas of preclinical development.

Please fill out the form below to download the Whitepaper